Koninklijke Philips EBITDA 2010-2025 | PHG

Koninklijke Philips annual and quarterly EBITDA history from 2010 to 2025. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
  • Koninklijke Philips EBITDA for the quarter ending March 31, 2025 was $0.454B, a 3778.53% increase year-over-year.
  • Koninklijke Philips EBITDA for the twelve months ending March 31, 2025 was $0.949B, a 25.12% increase year-over-year.
  • Koninklijke Philips 2024 annual EBITDA was $2.077B, a 66.26% increase from 2023.
  • Koninklijke Philips 2023 annual EBITDA was $1.249B, a 17.16% decline from 2022.
  • Koninklijke Philips 2022 annual EBITDA was $1.508B, a 32.61% decline from 2021.
Koninklijke Philips Annual EBITDA
(Millions of US $)
2024 $2,077
2023 $1,249
2022 $1,508
2021 $2,237
2020 $3,662
2019 $3,521
2018 $3,316
2017 $2,890
2016 $3,517
2015 $2,577
2014 $2,252
2013 $4,487
2012 $3,186
2011 $3,471
2010 $4,530
2009 $2,823
Koninklijke Philips Quarterly EBITDA
(Millions of US $)
2025-03-31 $454
2024-06-30 $879
2023-06-30 $242
2023-03-31 $-626
2022-06-30 $12
2021-06-30 $102
2020-06-30 $252
2019-06-30 $392
2018-06-30 $355
2017-06-30 $278
2016-12-31 $1,287
2016-09-30 $867
2016-06-30 $776
2016-03-31 $587
2015-12-31 $618
2015-09-30 $733
2015-06-30 $750
2015-03-31 $476
2014-12-31 $368
2014-09-30 $275
2014-06-30 $870
2014-03-31 $739
2013-12-31 $1,544
2013-09-30 $1,067
2013-06-30 $1,069
2013-03-31 $807
2012-12-31 $652
2012-09-30 $1,166
2012-06-30 $638
2012-03-31 $1,037
2011-12-31 $601
2011-09-30 $623
2011-06-30 $864
2011-03-31 $1,267
2010-12-31 $1,532
2010-09-30 $1,099
2010-06-30 $924
2010-03-31 $994
2009-12-31 $2,828
2009-09-30 $1,047
2009-06-30 $-658
2009-03-31 $181
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $21.553B $19.503B
Koninklijke Philips N.V. is the parent company of the Philips Group. The company realigned its three reporting operations into Diagnosis & Treatment businesses consists of Diagnostic Imaging, Ultrasound, Image-Guided Therapy and Enterprise Diagnostic Informatics businesses. Connected Care business comprises the Monitoring & Analytics, Therapeutic Care, Population Health Management, Sleep & Respiratory Care and Connected Care Informatics businesses. Personal Health business consists of the Oral Healthcare, Mother & Child Care and Personal Care. Other consists of Innovation, Emerging Businesses, IP Royalties, Central costs and Other. Notably, Philips completed the divestiture of Domestic Appliances business.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $229.693B 27.62
Boston Scientific (BSX) United States $154.617B 38.71
Stryker (SYK) United States $145.191B 30.36
EssilorLuxottica (ESLOY) France $128.660B 0.00
Medtronic (MDT) Ireland $104.194B 14.77
Haleon (HLN) United Kingdom $50.678B 28.85
Lonza Group Ag (LZAGY) Switzerland $49.121B 0.00
ResMed (RMD) United States $35.889B 26.96
GE HealthCare Technologies (GEHC) United States $32.579B 15.47
Agilent Technologies (A) United States $31.612B 20.53
Terumo (TRUMY) Japan $27.743B 36.03
Insulet (PODD) United States $22.770B 89.38
Zimmer Biomet Holdings (ZBH) United States $18.259B 11.73
Baxter (BAX) United States $15.693B 11.72
Smith & Nephew SNATS (SNN) United Kingdom $12.530B 0.00
Sunny Optical Technology (SNPTF) China $9.032B 0.00
Demant (WILYY) Denmark $8.637B 0.00
Bio-Rad Laboratories (BIO) United States $6.236B 21.70
Lantheus Holdings (LNTH) United States $5.132B 12.95
Prestige Consumer Healthcare (PBH) United States $4.168B 18.62
Perrigo (PRGO) Ireland $3.726B 9.44
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Haemonetics (HAE) United States $3.248B 14.79
ICU Medical (ICUI) United States $3.162B 23.32
Envista Holdings (NVST) United States $3.141B 26.10
GN Store Nord (GNNDY) Denmark $2.200B 18.22
QuidelOrtho (QDEL) United States $2.144B 14.74
LeMaitre Vascular (LMAT) United States $1.830B 40.91
AtriCure (ATRC) United States $1.660B 0.00
Acuren (TIC) United States $1.336B 0.00
Neogen (NEOG) United States $1.326B 16.97
AdaptHealth (AHCO) United States $1.225B 12.44
Kestra Medical Technologies (KMTS) United States $1.174B 0.00
Green Thumb Industries (GTBIF) United States $1.103B 24.81
BioLife Solutions (BLFS) United States $1.062B 0.00
Phibro Animal Health (PAHC) United States $0.993B 12.69
InMode (INMD) Israel $0.910B 9.17
CeriBell (CBLL) United States $0.621B 0.00
Evolus (EOLS) United States $0.600B 0.00
Curaleaf Holdings (CURLF) Canada $0.593B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.563B 0.00
Valneva SE (VALN) France $0.533B 0.00
Owens & Minor (OMI) United States $0.504B 4.18
Capricor Therapeutics (CAPR) United States $0.486B 0.00
Tilray Brands (TLRY) Canada $0.453B 0.00
Surmodics (SRDX) United States $0.418B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.366B 0.00
SNDL (SNDL) Canada $0.342B 0.00
Cresco Labs (CRLBF) United States $0.329B 0.00
Canopy Growth (CGC) Canada $0.325B 0.00
VAREX IMAGING (VREX) United States $0.324B 11.91
Aurora Cannabis (ACB) Canada $0.310B 55.20
Viemed Healthcare (VMD) United States $0.260B 21.90
Sanara MedTech (SMTI) United States $0.257B 0.00
ZimVie (ZIMV) United States $0.245B 11.14
Cerus (CERS) United States $0.242B 0.00
Verano Holdings (VRNOF) United States $0.240B 0.00
Sanuwave Health (SNWV) United States $0.236B 0.00
TriSalus Life Sciences (TLSI) United States $0.211B 0.00
OraSure Technologies (OSUR) United States $0.207B 0.00
Quanterix (QTRX) United States $0.205B 0.00
Brainsway (BWAY) Israel $0.202B 53.50
Biote (BTMD) United States $0.193B 5.43
Omeros (OMER) United States $0.184B 0.00
Organigram Global (OGI) Canada $0.181B 0.00
High Tide (HITI) Canada $0.181B 0.00
Utah Medical Products (UTMD) United States $0.176B 14.30
Exagen (XGN) United States $0.143B 0.00
FitLife Brands (FTLF) United States $0.135B 16.62
Jin Medical (ZJYL) China $0.119B 0.00
TerrAscend (TSNDF) Canada $0.119B 0.00
Agape ATP (ATPC) $0.093B 0.00
Fonar (FONR) United States $0.089B 11.48
Oramed Pharmaceuticals (ORMP) United States $0.088B 0.00
MacroGenics (MGNX) United States $0.088B 0.00
Veru (VERU) United States $0.077B 0.00
Quipt Home Medical (QIPT) United States $0.076B 0.00
Zynex (ZYXI) United States $0.075B 0.00
InterCure (INCR) Israel $0.070B 0.00
Apyx Medical (APYX) United States $0.063B 0.00
Jushi Holdings (JUSHF) United States $0.060B 0.00
ImmuCell (ICCC) United States $0.056B 0.00
Cytosorbents (CTSO) United States $0.053B 0.00
United Health Products (UEEC) United States $0.052B 0.00
Modular Medical (MODD) United States $0.047B 0.00
United-Guardian (UG) United States $0.039B 13.45
Rockwell Medical (RMTI) United States $0.033B 0.00
Nephros (NEPH) United States $0.031B 41.74
Safety Shot (SHOT) United States $0.026B 0.00
Allurion Technologies (ALUR) United States $0.019B 0.00
INLIF (INLF) $0.019B 0.00
Flora Growth (FLGC) United States $0.016B 0.00
Trinity Biotech (TRIB) Ireland $0.011B 0.00
Cellectar Biosciences (CLRB) United States $0.011B 0.00
Meihua Medical Technologies (MHUA) China $0.010B 0.00
Innovative Eyewear (LUCY) United States $0.009B 0.00
IM Cannabis (IMCC) Canada $0.006B 0.00
Senestech (SNES) United States $0.005B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00